IMMUNE SENSOR LLC has a total of 19 patent applications. It decreased the IP activity by 87.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are IMMUNE MODULATION INC, GLASKY ALVIN J and MUSCAGEN LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Singapore | 2 | |
#7 | WIPO (World Intellectual Property Organization) | 2 | |
#8 | Brazil | 1 | |
#9 | Israel | 1 | |
#10 | Japan | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Chen Zhijian | 17 |
#2 | Zhong Boyu | 17 |
#3 | Chen Chuo | 17 |
#4 | Sun Lijun | 17 |
#5 | Shi Heping | 16 |
#6 | Wei Qi | 11 |
#7 | Dai Yuanwei | 11 |
#8 | Li Jing | 6 |
#9 | Zhijian Chen | 2 |
#10 | Yuanwei Dai | 2 |
Publication | Filing date | Title |
---|---|---|
CN109475565A | CGAS agonist compounds | |
KR20190018408A | Cyclic di-nucleotide compounds and methods of use |